Skip to main content

Table 2 Adverse events by umbilical cord mesenchymal stem cell treatment within 12 months a

From: Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study

Patient Adverse events Severity Time (days) Related to MSCT
2 Herpesvirus infection AE 291 No relation
3 Herpesvirus infection AE 135 No relation
3 Herpesvirus infection AE 187 No relation
9 Death SAE 7 No relation
12 Tuberculosis infection AE 326 No relation
14 Death SAE 256 No relation
27 Death SAE 192 No relation
  1. aAE, Adverse event; MSCT, Mesenchymal stem cell treatment; SAE, Severe adverse event.